Abreos Biosciences Raises New Funding

San Diego-based Abreos Biosciences, a developer of biotechnology used for precision dosing of biological therapeutics, has raised a new round of funding, the company announced on Tuesday morning. Size of the funding was not announced. Abreos said the new funding round came from its existing investors, along with TLP Investment Partners LLC and its affiliates. Dr. Bradley Messmer is CEO and founder of Abreos. A recent regulatory filing indicates the round included at least $1.2M in funding. More information »